What's in the Epstein files? A reader's guide to the documents

Here is a guide to what the Justice Department has released about its investigation of Jeffrey Epstein and what to look for ...
Axios on MSN

Here's how the DOJ releases the Epstein files and how others are making them easier to read

The Department of Justice released a new batch of Epstein files on Tuesday, sending journalists and the public scrambling to ...
BMJ Open

Site-randomised trial of a multilevel digital intervention to reduce maternal morbidity and mortality: a study protocol

Introduction Compared with other high-income countries, the USA continues to have the highest rates of pregnancy-related and associated mortality and morbidity (PRAMM), particularly in rural areas and ...
Goldseiten

Champion Iron To Launch Cash Tender Offer To Acquire Rana Gruber, Receives Financial Support From La Caisse And A Term Loan Commitment From Scotiabank

Dec. 21, 2025 - , 22, 2025 - Champion Iron Ltd. today announced that it has entered into a transaction agreement with Rana Gruber ASA , a leading Norwegian producer of high-grade iron ore, on terms of ...

Portable Generator Market Size to Hit $2.9 Billion Opportunity by 2027 | MarketsandMarkets™

The global Portable Generator Market size is expected to grow from USD 2.2 billion in 2022 to USD 2.9 billion by 2027, at a CAGR of 6.0% according to a new report by MarketsandMarkets™. Electricity ...

Christopher Balter Launches the Second Chance Community Impact Scholarship to Support Future Leaders in Planning, Development, and Public Service

Christopher Balter Scholarship Christopher Balter Second Chance Community Impact Scholarship ORLANDO, Fla., Dec. 18, 2025 ...
United States ArmyOpinion

Outthinking Adversaries: The Future of Warfare in a Multi-Domain World

Military historians, professionals, and strategists attributed U.S. military victories in World Wars I and II to two basic ...
Agence France-Presse

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...